EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

An Integrated Approach Using Network Pharmacology and Experimental Validation to Reveal the Therapeutic Mechanism of Weifuchun in Treating Gastric Cancer

Ziyuan Wang, Zhipeng Zhang, Nisma Lena Bahaji Azami, Dengcheng Hui, Zheng Wang, Dong Xie, Guan Ye, Ningning Liu, Mingyu Sun

Journal of Medicinal Food · 2024

DOI: 10.1089/jmf.2024.k.0126 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Medicinal Food, 2024. Verfasst von Ziyuan Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Liver and Kidney Diseases, Institute of Liver Diseases, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Sha…. Hauptthemen laut MEDLINE: Stomach Neoplasms, Drugs, Chinese Herbal, Network Pharmacology, Apoptosis. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gastric cancer (GC) is a prevalent malignancy affecting the gastrointestinal tract. Weifuchun (WFC), a Chinese herbal prescription comprising red ginseng, Isodon amethystoides , and Fructus aurantii , is widely used in China for various chronic stomach disorders. However, its therapeutic role and mechanisms in treating GC remain unexplored. In a randomized, controlled, single-blind trial involving postoperative stages II and III GC patients, we compared adjuvant chemotherapy plus WFC (chemo plus WFC group) to adjuvant chemotherapy alone (chemo group) over 6 months. We assessed recurrence and metastasis rates and used systematic pharmacology to predict WFC’s active components, screen target genes, and construct network interaction maps, were validated through in vitro experiments. The combined therapy significantly reduced 2-year recurrence and metastasis rates. We identified 67 active ingredients, 211 drug target proteins, 1539 disease targets, 105 shared targets, and 188 signaling pathways associated with WFC. WFC impacted cell apoptosis, proliferation, and the inflammatory response, with top tumor-related signaling pathways involving 5'-adenosine monophosphate-activated protein kinase (AMPK), mitogen-activated protein kinase, nuclear factor kappa-B (NFKB), and apoptosis. In vitro, WFC inhibited proliferation and migration while inducing apoptosis in GC cells, reduced VEGFA , TNFa , and IL6 expressions. Immunocytochemistry showed increased p-AMPK staining, and molecular analysis revealed decreased NFKB and phosphorylation of extracellular-regulated protein kinase 1/2 (ERK1/2) levels, increased p-AMPK and BAX protein levels in WFC-treated cells, effects reversed by Compound C. WFC’s antitumor effects involve AMPK-dependent ERK1/2 and NFKB pathways, regulating proliferation, migration, and apoptosis in GC cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsDrugs, Chinese HerbalNetwork PharmacologyApoptosisCell ProliferationHumansMiddle AgedMaleFemaleNF-kappa BCell Line, TumorSignal TransductionAgedSingle-Blind MethodAMP-Activated Protein Kinases

Stichwörter der Autor:innen

Weifuchunbioinformatics analysisclinical trialgastric cancermechanismnetwork pharmacology

Substanzen

Drugs, Chinese HerbalNF-kappa BAMP-Activated Protein Kinases

Autor:innen und Institutionen

  • Key Laboratory of Liver and Kidney Diseases, Institute of Liver Diseases, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Department of Pathology, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Shanghai Municipal Hospital of Traditional Chinese Medicine, Institute of Oncology, Shanghai University of Traditional Chinese Medicine (TCM), Shanghai, China.
  • Central Research Institute of Shanghai Pharmaceutical Group Co, Ltd, Shanghai, China.
  • Department of Medical Oncology and Cancer Institute, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

Zitieren

APA

Wang, Z., Zhang, Z., Azami, N. L. B., Hui, D., Wang, Z., Xie, D., Ye, G., Liu, N., & Sun, M. (2024). An Integrated Approach Using Network Pharmacology and Experimental Validation to Reveal the Therapeutic Mechanism of Weifuchun in Treating Gastric Cancer. Journal of Medicinal Food. https://doi.org/10.1089/jmf.2024.k.0126

Vancouver

Wang Z, Zhang Z, Azami NLB, Hui D, Wang Z, Xie D, et al. An Integrated Approach Using Network Pharmacology and Experimental Validation to Reveal the Therapeutic Mechanism of Weifuchun in Treating Gastric Cancer. Journal of Medicinal Food. 2024. doi:10.1089/jmf.2024.k.0126

BibTeX
@article{Wang2024,
  author = {Wang, Ziyuan and Zhang, Zhipeng and Azami, Nisma Lena Bahaji and Hui, Dengcheng and Wang, Zheng and Xie, Dong and Ye, Guan and Liu, Ningning and Sun, Mingyu},
  title = {An Integrated Approach Using Network Pharmacology and Experimental Validation to Reveal the Therapeutic Mechanism of Weifuchun in Treating Gastric Cancer},
  journal = {Journal of Medicinal Food},
  year = {2024},
  doi = {10.1089/jmf.2024.k.0126}
}
Kostenlos starten →